Clinical Trials Directory

Trials / Completed

CompletedNCT00202475

Collection of Autologous Blood Products by Double Erythrocytapheresis

Collection of Autologous Blood Products by Double Erythrocytapheresis - Cost Effectiveness Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Sanquin Research & Blood Bank Divisions · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood. The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon. Also, successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared.

Detailed description

The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood. The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon. Also, successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared.

Conditions

Interventions

TypeNameDescription
PROCEDUREeythrocytapheresismachinal collection of erythrocytes
PROCEDUREwhole blood collectioncollection of whole blood

Timeline

Start date
2003-09-01
Primary completion
2006-09-01
Completion
2007-12-01
First posted
2005-09-20
Last updated
2009-10-20

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00202475. Inclusion in this directory is not an endorsement.

Collection of Autologous Blood Products by Double Erythrocytapheresis (NCT00202475) · Clinical Trials Directory